Touchstone International Medical Science Co., Ltd. (SHA:688013)

China · Delayed Price · Currency is CNY

25.16

-0.06 (-0.24%)

Aug 25, 2026, 10:45 AM CST

SHA:688013 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	316.57	326.73	272.37	253.65	232.03	213.74
Revenue Growth	13.88%	19.96%	7.38%	9.31%	8.56%	30.85%
Gross Profit	205.42	208.2	158.73	141.85	132.23	122.47
Operating Income	68.47	72.18	46.34	29.58	33.27	28.41
Net Income	81.69	85.19	51.89	47.31	43.2	41.42
Earnings Per Share	1.01	1.05	0.64	0.58	0.53	0.51
EPS Growth	52.52%	64.06%	10.35%	9.43%	3.92%	-5.56%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	211.59
Export	115.14
Total	326.73

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	285.73	294.01	395.12	430.05	362.34	430.91
Total Debt	75.44	50.46	2.02	1.96	0.96	-
Net Cash (Debt)	210.3	243.55	393.1	428.1	361.38	430.91
Net Cash Growth	-40.07%	-38.05%	-8.18%	18.46%	-16.14%	13.59%
Net Cash Per Share	2.59	3.00	4.85	5.25	4.43	5.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	56.94	71.99	53.41	82.95	50.4	60.98
Capital Expenditures	-92.41	-90.75	-41.94	-18.41	-47.67	-9.21
Free Cash Flow	-35.47	-18.76	11.47	64.54	2.73	51.77
Free Cash Flow Growth	-	-	-82.23%	2263.10%	-94.73%	48.80%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.89%	63.72%	58.28%	55.92%	56.99%	57.30%
Operating Margin	21.63%	22.09%	17.02%	11.66%	14.34%	13.29%
Pretax Margin	28.50%	29.13%	20.13%	18.90%	19.86%	21.57%
Profit Margin	25.81%	26.07%	19.05%	18.65%	18.62%	19.38%
FCF Margin	-11.21%	-5.74%	4.21%	25.44%	1.18%	24.22%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	1.600	1.300	1.000	-	0.250	0.200
Dividend Per Share Growth	-13.33%	30.00%	-	-	25.00%	0%
Dividend Yield	6.10%	2.79%	6.18%	-	1.46%	0.90%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	25.06	45.11	26.90	35.33	36.02	49.14
P/FCF Ratio	-	-	121.71	25.90	569.75	39.31
PS Ratio	6.41	11.76	5.13	6.59	6.71	9.52